Jan Menne - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Jan Menne

Showing results (111-120 of 113) with videos related to

Pageof 12

Sort By:

You have reached the last page of results.This site can display upto 113 results.

Blood|February 11, 2026

Revisiting Clinical Response and Refractoriness in Immune Thrombotic Thrombocytopenic PurpuraLucas Kühne, Thomas Osterholt, Maximilian Suer, et al.

Journal of Thrombosis and Haemostasis : JTH|January 25, 2023

Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpuraLinus A Völker, Jessica Kaufeld, Gesa Balduin, et al.

BMJ (Clinical Research Ed.)|July 21, 2012

Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control studyJan Menne, Martin Nitschke, Robert Stingele, et al.

Pageof 12

Search research articles

Showing results (111-120 of 113) with videos related to

Sort By:

Pageof 12

You have reached the last page of results.This site can display upto 113 results.

Blood|February 11, 2026

Revisiting Clinical Response and Refractoriness in Immune Thrombotic Thrombocytopenic PurpuraLucas Kühne, Thomas Osterholt, Maximilian Suer, et al.

Journal of Thrombosis and Haemostasis : JTH|January 25, 2023

Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpuraLinus A Völker, Jessica Kaufeld, Gesa Balduin, et al.

BMJ (Clinical Research Ed.)|July 21, 2012

Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control studyJan Menne, Martin Nitschke, Robert Stingele, et al.

Pageof 12